Table 1

Comparison of clinical characteristics between cohort of the training set and test set

Cohort of the training set (n=15 365)Cohort of the test set
(n=4215)
P value
Female, n (%)5868 (38.2)1518 (36.0)0.010
Age, year, median (IQR)70 (60–79)71 (60–79)0.012
Atrial fibrillation, n (%)3274 (21.3)804 (19.1)0.002
Congestive heart failure, n (%)338 (2.2)75 (1.8)0.104
Coronary heart disease, n (%)1283 (8.4)303 (7.2)0.015
Family history of cardiovascular disease, n (%)174 (1.1)25 (0.6)0.002
Smoking, n (%)4637 (30.2)1181 (28.0)0.007
Hyperlipidaemia, n (%)890 (5.8)199 (4.7)0.008
Diabetes mellitus, n (%)2497 (16.3)702 (16.7)0.526
Hypertension, n (%)9815 (63.9)2624 (62.3)0.053
History of stroke/TIA, n (%)1968 (12.8)560 (13.3)0.422
Hyperhomocysteinaemia, n (%)1011 (6.6)237 (5.6)0.026
Prior anticoagulation therapy, n (%)338 (2.2)83 (2.0)0.400
Prior antiplatelet therapy, n (%)2191 (14.3)558 (13.2)0.094
LVO, n (%)4417 (28.7)1279 (30.3)0.044
Systolic blood pressure, mm Hg, median (IQR)154 (139–168)153 (139–167)0.450
Diastolic blood pressure, mm Hg, median (IQR)85 (76–94)84 (76–94)0.065
NIHSS sum, median (IQR)6 (3–13)5 (2–12)<0.001
NIHSS items
 LOC, median (IQR)0 (0–0)0 (0–0)0.288
 LOC questions, median (IQR)0 (0–1)0 (0–0)0.064
 LOC commands, median (IQR)0 (0–0)0 (0–0)0.020
 Gaze deviation, median (IQR)0 (0–0)0 (0–0)0.001
 Visual field test, median (IQR)0 (0–0)0 (0–0)0.341
 Facial palsy, median (IQR)1 (0–1)1 (0–1)0.003
 Motor left arm, median (IQR)0 (0–2)0 (0–2)<0.001
 Motor right arm, median (IQR)0 (0–2)0 (0–2)0.258
 Motor left leg, median (IQR)0 (0–2)0 (0–2)<0.001
 Motor right leg, median (IQR)0 (0–2)0 (0–2)0.063
 Limb ataxia, median (IQR)0 (0–0)0 (0–0)0.002
 Sensory, median (IQR)1 (0–1)1 (0–1)0.003
 Aphasia, median (IQR)0 (0–2)0 (0–2)0.003
 Dysarthria, median (IQR)1 (0–1)1 (0–1)0.014
 Extinction and inattention, median (IQR)0 (0–0)0 (0–0)0.678
  • LOC, level of consciousness; LVO, large vessel occlusion; NIHSS, National Institutes of Health Stroke Scale; TIA, transient ischaemic attack.